UBS Group’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-411,137
| Closed | -$11.1M | – | 9896 |
|
2022
Q4 | $11.1M | Buy |
411,137
+382,529
| +1,337% | +$10.3M | ﹤0.01% | 1325 |
|
2022
Q3 | $515K | Sell |
28,608
-55,460
| -66% | -$998K | ﹤0.01% | 3345 |
|
2022
Q2 | $1.04M | Sell |
84,068
-67,713
| -45% | -$841K | ﹤0.01% | 2861 |
|
2022
Q1 | $2.02M | Sell |
151,781
-82,947
| -35% | -$1.11M | ﹤0.01% | 2643 |
|
2021
Q4 | $3.66M | Buy |
234,728
+98,190
| +72% | +$1.53M | ﹤0.01% | 2392 |
|
2021
Q3 | $3.06M | Buy |
136,538
+64,689
| +90% | +$1.45M | ﹤0.01% | 2426 |
|
2021
Q2 | $1.64M | Sell |
71,849
-48,614
| -40% | -$1.11M | ﹤0.01% | 2885 |
|
2021
Q1 | $2.48M | Sell |
120,463
-101,953
| -46% | -$2.1M | ﹤0.01% | 2576 |
|
2020
Q4 | $6.14M | Buy |
222,416
+120,752
| +119% | +$3.34M | ﹤0.01% | 1696 |
|
2020
Q3 | $1.43M | Buy |
101,664
+86,778
| +583% | +$1.22M | ﹤0.01% | 2689 |
|
2020
Q2 | $307K | Buy |
14,886
+10,449
| +235% | +$215K | ﹤0.01% | 3722 |
|
2020
Q1 | $34K | Sell |
4,437
-7,598
| -63% | -$58.2K | ﹤0.01% | 5236 |
|
2019
Q4 | $187K | Buy |
12,035
+4,885
| +68% | +$75.9K | ﹤0.01% | 4643 |
|
2019
Q3 | $37K | Buy |
7,150
+6,608
| +1,219% | +$34.2K | ﹤0.01% | 5419 |
|
2019
Q2 | $5K | Sell |
542
-650
| -55% | -$6K | ﹤0.01% | 6527 |
|
2019
Q1 | $28K | Sell |
1,192
-246
| -17% | -$5.78K | ﹤0.01% | 5192 |
|
2018
Q4 | $23K | Buy |
1,438
+146
| +11% | +$2.34K | ﹤0.01% | 5760 |
|
2018
Q3 | $34K | Buy |
+1,292
| New | +$34K | ﹤0.01% | 5550 |
|
2018
Q2 | – | Sell |
-1,025
| Closed | -$22K | – | 7228 |
|
2018
Q1 | $22K | Buy |
+1,025
| New | +$22K | ﹤0.01% | 5493 |
|
2017
Q4 | – | Sell |
-1,184
| Closed | -$18K | – | 7047 |
|
2017
Q3 | $18K | Buy |
1,184
+1,069
| +930% | +$16.3K | ﹤0.01% | 5638 |
|
2017
Q2 | $1K | Sell |
115
-1,628
| -93% | -$14.2K | ﹤0.01% | 6585 |
|
2017
Q1 | $20K | Sell |
1,743
-1,282
| -42% | -$14.7K | ﹤0.01% | 5232 |
|
2016
Q4 | $38K | Buy |
+3,025
| New | +$38K | ﹤0.01% | 5126 |
|